查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1532126

細胞解離市場：依產品、依組織類型、依解離、依最終使用者、依地區、機會、預測，2017-2031年

Cell Dissociation Market Assessment, By Product, By Tissue Type, By Dissociation, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 236 Pages | 商品交期: 3-5個工作天內

價格

預計全球細胞解離市場規模將從2023年的 4.6303億美元成長到2031年的 14.7153億美元，在2024-2031年預測期內年複合成長率為 15.55%。市場出現了顯著成長，預計在預測期內將出現進一步的多方面成長。

細胞解離，也稱為胰蛋白酶消化，是使用蛋白水解酶將貼壁細胞從細胞培養容器中分離出來時發生的過程。這個過程對於細胞的進一步消耗是必要的。細胞解離試劑的膠原纖維降解和蛋白水解活性可以透過將細胞組織和細胞從容器的玻璃或塑膠表面釋放來增加細胞活力並增強分離效果。

市場擴張是由細胞分離用品、工具和製程的持續創新和技術開發所推動的。細胞解離需求是由技術進步所驅動的。這些技術提高了效率、縮短了週期時間並提高了程序效率。人們對感染控制實踐、病人安全和醫療保健相關感染（HAI）的認識不斷提高，推動了醫療機構、實驗室和臨床環境中滅菌服務的使用。為了防止疾病傳播，這些過程提供了新的治療模式，對於研究人員創建更好的醫療保健解決方案非常重要。

本報告調查了全球細胞分離市場，並提供了市場概述，包括依產品、組織類型、分離、最終用戶、區域趨勢和參與市場的公司概況。

目錄

第1章 專案範圍與定義

第2章 研究方法

第3章 執行摘要

第4章 2017-2031年全球細胞分離市場前景

  • 市場規模分析與預測
  • 市佔率分析與預測
  • 2023年市場地圖分析
    • 依產品
    • 依組織類型
    • 依解離
    • 依最終用戶
    • 依地區

第5章 北美細胞解離市場展望，2017-2031

第6章 歐洲細胞分離市場展望，2017-2031

第7章 亞太地區細胞解離市場展望，2017-2031

第8章 南美洲細胞解離市場前景，2017-2031

第9章 中東與非洲細胞解離市場前景，2017-2031

第10章 供需分析

第11章 進出口分析

第12章 價值鏈分析

第13章 波特五力分析

第14章 PESTLE分析

第15章 價格分析

第16章 市場動態

  • 市場驅動因素
  • 市場挑戰

第17章 市場趨勢與發展

第18章 監理架構與創新

第19章 專利狀況

第20章 個案研究

第21章 競爭態勢

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 名參與公司的 SWOT 分析
  • 市場前10位主要參與者的情況
    • Thermo Fisher Scientific Inc.
    • Miltenyi Biotec B.V. & Co. KG
    • Becton, Dickinson and Company
    • Satorius AG
    • Novartis AG
    • Merck KGaA
    • Global Life Sciences Solutions USA LLC (Cytiva)
    • Danaher Corporation
    • Corning Incorporated
    • Promega Corporation

第22章 策略建議

第23章 查詢及免責聲明

Product Code: MX11741

Global cell dissociation market is projected to witness a CAGR of 15.55% during the forecast period 2024-2031, growing from USD 463.03 million in 2023 to USD 1471.53 million in 2031. The market has undergone substantial growth and is expected to further grow manifold in the forecast period.

Cell dissociation, also known as trypsinization, is a process that occurs when adherent cells are separated from the cell culture vessel using a proteolytic enzyme. This process is necessary for the cells to be further consumed. Collagenolytic and proteolytic activities of cell dissociation reagents can increase the viability of the cells and the effectiveness of isolation by releasing the cell tissues and lines from the glass and plastic surfaces of the container.

Market expansion is fueled by ongoing innovation and technological developments in cell dissociation supplies, tools, and processes. The need for cell dissociation is being driven by advancements in technology. These technologies improve efficiency, shorten cycle times, and improve procedure efficacy. The use of sterilization services in medical facilities, labs, and clinical settings is fueled by growing awareness of infection control practices, patient safety, and healthcare-associated infections (HAIs). To prevent the spread of diseases, these processes are essential in providing newer therapeutic models and help researchers produce better healthcare solutions, which is essential.

To meet changing risks and guarantee protection against newly developing infections and resistant strains, cell dissociation providers must constantly innovate and adapt. For instance, in January 2024, Miltenyi Biotec B.V. & Co. KG made the announcement that the company would merge with SynGen Inc. Through this agreement, SynGen Inc.'s cutting-edge cell processing technology and Miltenyi Biotec B.V. & Co. KG's magnetic cell separation know-how were anticipated to be combined, improving both companies' capacities for processing and cell dissociation.

Rising Investments Alongside Rising Mergers and Acquisitions Leading to Market Expansion

The market for cell dissociation is expanding due to rising funding and investments and an increase in mergers and acquisitions. Significant financing for research and development in cell dissociation technologies has come from government efforts, private equity firms, and venture capitalists. Companies can innovate and improve their product with this financial help, which increases their market presence. Furthermore, mergers and acquisitions have greatly aided the expansion of the market. Through these strategic alliances, businesses can pool resources, take use of mutual advantages, and quicken the development and launch of new products. Businesses may meet a wider range of client needs and take advantage of new prospects in the cell dissociation sector by combining technology and skills.

Moreover, heightened investment and consolidation endeavors have nurtured a competitive environment, motivating enterprises to distinguish themselves via innovative technologies and exceptional customer support. In the end, this rivalry benefits all parties involved by fostering innovation and increasing manufacturing and distribution efficiencies. Increasing financing, smart mergers and acquisitions, and other factors are acting together to propel the cell dissociation market's growth and improvement in therapeutic applications and scientific research. For instance, a majority stake of a high-quality cell dissociation reagents provider called Sartorius CellGenix GmbH was acquired by Sartorius AG in October 2023. The strategic alliance between the two can enhance Sartorius AG's product offerings in the cell culture market and can help expand its global footprint.

Growing Prevalence of Infectious Diseases is Fueling Market Growth

The market for cell dissociation is expanding as infectious diseases are becoming more common globally. The need for innovative biomedical research and treatment approaches is rising as infectious illnesses remain a threat to world health. In this context, cell dissociation is essential because it allows researchers to focus on individual cells that are involved in immune responses, infection routes, and disease mechanisms.

To remove and culture cells from different tissues and organs impacted by infectious pathogens, cell dissociation procedures are crucial. Through this approach, scientists can investigate prospective treatments like vaccinations and antiviral medications, analyze the behavior of viruses, and create diagnostic tools. Therefore, it is critical to develop effective and efficient cell dissociation techniques to improve treatment quality and understanding of infectious illnesses. Additionally, the need to address emerging pandemic, newly developing infectious illnesses and antibiotic resistance motivates continued investment in cell dissociation technologies.

Research and development initiatives to improve cell dissociation techniques broaden their uses in infectious disease researches funded by governments, non-profits, and pharmaceutical firms. In summary, the growing incidence of infectious diseases highlights the vital role played by cell dissociation in promoting biomedical research and creating novel approaches to address global health issues, which in turn drives the market for cell dissociation. For instance, the Zika virus epidemics in various countries in 2023 increased the necessity for sophisticated research instruments to comprehend the virus's effect on neural cells, especially in developing and pregnant women and newborns. To isolate and analyze brain stem cells and other pertinent cell types impacted by Zika virus infection, cell dissociation techniques are crucial.

Pharmaceuticals and Biotechnology Companies to Elevate Market Size

The expansion of the cell dissociation market is largely due to the dominance of biotechnology and pharmaceutical firms. These companies are at the forefront of creating novel treatments, vaccinations, and diagnostics which significantly rely on cell dissociation methods for their investigative work. Cell dissociation techniques are used by pharmaceutical corporations to separate particular cell types for drug screening, toxicity assessments, and effectiveness research. These techniques are used by biotechnology companies to cultivate and manipulate cells in controlled conditions to manufacture biologicals, such as recombinant proteins and monoclonal antibodies. The pharmaceutical and biotechnology industries are very competitive and encourage constant innovation in cell dissociation technologies. Businesses make large investments in automation systems, culture media formulations, and dissociation methods to improve the productivity and repeatability of cell-based tests and production processes.

Additionally, strategic alliances and partnerships between biotech startups and industry titans in the pharmaceutical sector drive market expansion. By combining complementary knowledge and resources, these partnerships shorten the time for the development of new products and increase their market share. The prevalence of biotechnology and pharmaceutical industries fuels the need for specialized tools and supplies for cell dissociation operations.

The broad spectrum of suppliers and service providers that are supported by this strong industry ecosystem adds to the overall growth of the cell dissociation market. In conclusion, the importance of pharmaceutical and biotechnology businesses as key players in medicinal development and biomedical research highlights their critical role in propelling growth and development in the cell dissociation market. The emergence of cell-based therapeutics for the treatment of cancer provides a relevant illustration of how the dominance of pharmaceutical and biotechnology corporations drives the cell dissociation market. By 2023, businesses such as Novartis AG and Kite Pharma (a Gilead Sciences, Inc. subsidiary were at the forefront of applying the novel cancer immunotherapy technique known as chimeric antigen receptor (CAR) T-cell therapy.

North America Dominates the Cell Dissociation Market

North America's sophisticated research and healthcare system and strict regulations helped it become the leading region in the global cell dissociation market in 2023. In North America, the market for cell dissociation is anticipated to increase significantly due to factors including the highly developed biopharmaceutical industry, which permits substantial research and development of innovative treatments, and rising firm investment in the development of new therapies. The American Cancer Society released its Cancer Facts & Figures 2023 report, which projected 0.6 million cancer deaths and 1.9 million new cancer cases to be diagnosed in the United States in 2023.

Furthermore, 54.1 million Americans, or 16% of the overall population, were 65 years or older in 2019. By 2040, this number is expected to rise to 21.6% of the overall population. Therefore, it is projected that the country's growing elderly population and the prevalence of chronic diseases will increase the prospects for the development of new biopharmaceuticals, propelling the expansion of the studied market. Furthermore, there is a need for new biopharmaceuticals due to the prevalence of diabetes, cardiovascular diseases (CVDs), and cancer. As a result, the country will have prospects for novel medicines, which will fuel the market expansion.

Future Market Scenario (2024 - 2031F)

Main factors contributing to the anticipated growth of cell dissociation market are the rising awareness about patient safety and infection control, increasing prevalence of pathogens and microorganisms and thus the rising requirement of better therapies. Given that technology is advancing, innovative technology in this field is expected to be introduced. Players in this market are expanding at an un-paralleled rate, introducing cost-effective and efficient technologies. Policies formulated by welfare bodies and government are greatly fueling the market expansion. For instance, a recombinant enzyme for cell dissociation called Gibco TrypLE Express Enzyme was introduced by Thermo Fisher Scientific Inc. in March 2024. The product is intended to offer a more effective and safer substitute for conventional trypsin, leading to better results in cell culture.

Key Players Landscape and Outlook

Several companies are expanding their business by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed cell dissociation technologies to help researchers and market players strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.

For instance, Promega Corporation was acquired by Merck KGaA with the purpose of enhancing its cell dissociation portfolio. Through this acquisition, the product portfolio of Merck KGaA and enzymatic dissociation technologies of Promega Corporation would be combined to improve the dependability and efficiency of cell culture procedures.

To improve its cell dissociation capabilities, Danaher Corporation purchased Global Life Sciences Solutions USA LLC (Cytiva)in February 2024. Cytiva's proficiency in cell processing technologies enhances Danaher Corporation's biopharmaceutical production solutions by supplementing its current portfolio.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Cell Dissociation Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Product
      • 4.2.1.1. Enzymatic Dissociation Agents
        • 4.2.1.1.1. Collagenase
        • 4.2.1.1.2. Trypsin
        • 4.2.1.1.3. Papain
        • 4.2.1.1.4. Elastase
        • 4.2.1.1.5. DNase
        • 4.2.1.1.6. Others
      • 4.2.1.2. Non-Enzymatic Dissociation Agents
      • 4.2.1.3. Instruments and Accessories
    • 4.2.2. By Tissue Type
      • 4.2.2.1. Connective Tissue
      • 4.2.2.2. Epithelial Tissue
      • 4.2.2.3. Others
    • 4.2.3. By Dissociation
        • 4.2.3.1.1. Tissue Dissociation
        • 4.2.3.1.2. Cell Detachment
    • 4.2.4. By End-user
      • 4.2.4.1. Pharmaceuticals and Biotechnology Companies
      • 4.2.4.2. Academic and Research Institutes
      • 4.2.4.3. Others
    • 4.2.5. By Region
      • 4.2.5.1. North America
      • 4.2.5.2. Europe
      • 4.2.5.3. Asia-Pacific
      • 4.2.5.4. South America
      • 4.2.5.5. Middle East and Africa
    • 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Product
    • 4.3.2. By Tissue Type
    • 4.3.3. By Dissociation
    • 4.3.4. By End-user
    • 4.3.5. By Region

5. North America Cell Dissociation Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Product
      • 5.2.1.1. Enzymatic Dissociation Agents
        • 5.2.1.1.1. Collagenase
        • 5.2.1.1.2. Trypsin
        • 5.2.1.1.3. Papain
        • 5.2.1.1.4. Elastase
        • 5.2.1.1.5. DNase
        • 5.2.1.1.6. Others
      • 5.2.1.2. Non-Enzymatic Dissociation Agents
      • 5.2.1.3. Instruments and Accessories
    • 5.2.2. By Tissue Type
      • 5.2.2.1. Connective Tissue
      • 5.2.2.2. Epithelial Tissue
      • 5.2.2.3. Others
    • 5.2.3. By Dissociation
      • 5.2.3.1. Tissue Dissociation
      • 5.2.3.2. Cell Detachment
    • 5.2.4. By End-user
      • 5.2.4.1. Pharmaceuticals and Biotechnology Companies
      • 5.2.4.2. Academic and Research Institutes
      • 5.2.4.3. Others
    • 5.2.5. By Country Share
      • 5.2.5.1. United States
      • 5.2.5.2. Canada
      • 5.2.5.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Cell Dissociation Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Product
          • 5.3.1.2.1.1. Enzymatic Dissociation Agents
          • 5.3.1.2.1.1.1. Collagenase
          • 5.3.1.2.1.1.2. Trypsin
          • 5.3.1.2.1.1.3. Papain
          • 5.3.1.2.1.1.4. Elastase
          • 5.3.1.2.1.1.5. DNase
          • 5.3.1.2.1.1.6. Others
          • 5.3.1.2.1.2. Non-Enzymatic Dissociation Agents
          • 5.3.1.2.1.3. Instruments and Accessories
        • 5.3.1.2.2. By Tissue Type
          • 5.3.1.2.2.1. Connective Tissue
          • 5.3.1.2.2.2. Epithelial Tissue
          • 5.3.1.2.2.3. Others
        • 5.3.1.2.3. By Dissociation
          • 5.3.1.2.3.1. Tissue Dissociation
          • 5.3.1.2.3.2. Cell Detachment
        • 5.3.1.2.4. By End-user
          • 5.3.1.2.4.1. Pharmaceuticals and Biotechnology Companies
          • 5.3.1.2.4.2. Academic and Research Institutes
          • 5.3.1.2.4.3. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Cell Dissociation Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Cell Dissociation Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Cell Dissociation Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Cell Dissociation Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Thermo Fisher Scientific Inc.
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 21.3.2. Miltenyi Biotec B.V. & Co. KG
    • 21.3.3. Becton, Dickinson and Company
    • 21.3.4. Satorius AG
    • 21.3.5. Novartis AG
    • 21.3.6. Merck KGaA
    • 21.3.7. Global Life Sciences Solutions USA LLC (Cytiva)
    • 21.3.8. Danaher Corporation
    • 21.3.9. Corning Incorporated
    • 21.3.10. Promega Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 2. Global Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 3. Global Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 4. Global Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 5. Global Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 6. Global Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Cell Dissociation Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 9. North America Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 10. North America Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 11. North America Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 12. North America Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 13. North America Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Cell Dissociation Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 16. United States Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 17. United States Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 18. United States Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 19. United States Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 20. United States Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 22. Canada Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 23. Canada Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 24. Canada Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 25. Canada Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 26. Canada Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 28. Mexico Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 29. Mexico Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 30. Mexico Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 31. Mexico Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 32. Mexico Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 34. Europe Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 35. Europe Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 36. Europe Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 37. Europe Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 38. Europe Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Cell Dissociation Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 41. Germany Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 42. Germany Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 43. Germany Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 44. Germany Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 45. Germany Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 47. France Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 48. France Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 49. France Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 50. France Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 51. France Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 53. Italy Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 54. Italy Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 55. Italy Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 56. Italy Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 57. Italy Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 59. United Kingdom Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 60. United Kingdom Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 61. United Kingdom Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 62. United Kingdom Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 63. United Kingdom Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 65. Russia Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 66. Russia Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 67. Russia Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 68. Russia Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 69. Russia Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 71. Netherlands Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 72. Netherlands Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 73. Netherlands Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 74. Netherlands Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 75. Netherlands Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 77. Spain Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 78. Spain Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 79. Spain Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 80. Spain Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 81. Spain Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 83. Turkey Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 84. Turkey Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 85. Turkey Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 86. Turkey Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 87. Turkey Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 89. Poland Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 90. Poland Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 91. Poland Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 92. Poland Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 93. Poland Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 95. South America Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 96. South America Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 97. South America Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 98. South America Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 99. South America Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Cell Dissociation Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 102. Brazil Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 103. Brazil Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 104. Brazil Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 105. Brazil Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 106. Brazil Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 108. Argentina Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 109. Argentina Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 110. Argentina Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 111. Argentina Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 112. Argentina Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 114. Asia-Pacific Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 115. Asia-Pacific Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 116. Asia-Pacific Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 117. Asia-Pacific Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 118. Asia-Pacific Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Cell Dissociation Market Share (%), By Country, 2017-2031F
  • Figure 120. India Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 121. India Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 122. India Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 123. India Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 124. India Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 125. India Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 127. China Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 128. China Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 129. China Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 130. China Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 131. China Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 133. Japan Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 134. Japan Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 135. Japan Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 136. Japan Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 137. Japan Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 139. Australia Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 140. Australia Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 141. Australia Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 142. Australia Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 143. Australia Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 145. Vietnam Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 146. Vietnam Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 147. Vietnam Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 148. Vietnam Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 149. Vietnam Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 151. South Korea Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 152. South Korea Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 153. South Korea Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 154. South Korea Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 155. South Korea Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 157. Indonesia Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 158. Indonesia Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 159. Indonesia Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 160. Indonesia Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 161. Indonesia Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 163. Philippines Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 164. Philippines Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 165. Philippines Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 166. Philippines Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 167. Philippines Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 169. Middle East & Africa Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 170. Middle East & Africa Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 171. Middle East & Africa Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 172. Middle East & Africa Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 173. Middle East & Africa Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Cell Dissociation Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 176. Saudi Arabia Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 177. Saudi Arabia Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 178. Saudi Arabia Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 179. Saudi Arabia Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 180. Saudi Arabia Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 182. UAE Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 183. UAE Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 184. UAE Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 185. UAE Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 186. UAE Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Cell Dissociation Market, By Value, In USD Million, 2017-2031F
  • Figure 188. South Africa Cell Dissociation Market, By Volume, In Thousand Units, 2017-2031F
  • Figure 189. South Africa Cell Dissociation Market Share (%), By Product, 2017-2031F
  • Figure 190. South Africa Cell Dissociation Market Share (%), By Tissue Type, 2017-2031F
  • Figure 191. South Africa Cell Dissociation Market Share (%), By Dissociation, 2017-2031F
  • Figure 192. South Africa Cell Dissociation Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Product Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194. By Tissue Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195. By Dissociation Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023